Table 2.
Age group |
Crude prevalence |
Crude prevalence after excluding persons on therapy for hypertension |
---|---|---|
% (95% CI) | % (95% CI) | |
18-29 y | 2.7% (1.1% to 6.7%) | 2.7% (1.1% to 6.7%) |
30-39 y | 16% (12% to 20%) | 15% (12% to 20%) |
40-49 y | 28% (24% to 32%) | 26% (22% to 31%) |
50-59 y | 44% (38% to 50%) | 42% (36% to 49%) |
60-69 y | 58% (47% to 67%) | 55% (44% to 66%) |
70-77 y | 73% (43% to 90%) | 75% (41% to 93%) |
Overall | 28% (25% to 30%) | 26% (24% to 29%) |